Gili Regev-Yochay

Instructor

Epidemiology, Harvard T.H. Chan School of Public Health

Departments

Department of Epidemiology

Biography

Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study.

Joseph G, Margalit I, Weiss-Ottolenghi Y, Rubin C, Murad H, Gardner RC, Barda N, Ben-Shachar E, Indenbaum V, Gilboa M, Alroy-Preis S, Kreiss Y, Lustig Y, Regev-Yochay G. Viruses 2024 Dec 20
Case-fatality rate of invasive pneumococcal disease caused by various serotypes-an analysis of nationwide surveillance data from Israel, 2009-2018.

Wieder-Finesod A, Yahav D, Rubin C, Hashkor S, Southern J, Mircus G, Theilacker C, Dagan R, Regev-Yochay G. Clin Microbiol Infect 2025
SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral response.

Margalit I, Weiss-Ottolenghi Y, Panet E, Indenbaum V, Zuckerman NS, Joseph G, Peretz Y, Barda N, Lustig Y, Regev-Yochay G. Int J Infect Dis 2024
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers.

Canetti M, Barda N, Lustig Y, Weiss-Ottolenghi Y, Indenbaum V, Peretz Y, Zuckerman N, Asraf K, Amit S, Kreiss Y, Regev-Yochay G. Vaccine 2024 Dec 02
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.

Lustig Y, Barda N, Weiss-Ottolenghi Y, Indenbaum V, Margalit I, Asraf K, Doolman R, Chalkias S, Das R, Elfatarany G, Harats D, Kreiss Y, Regev-Yochay G. Vaccine 2024 Sep 17

In addition to our degree programs, we offer highly targeted executive and continuing education, directed and taught by Harvard faculty.